("Deltex Medical" or the "Company")
Issue of equity
Deltex Medical Group plc, the global leader in oesophageal Doppler monitoring ("ODM"), announces that it has issued a total of 354,619 new ordinary shares of 1p each in the Company ("New Ordinary Shares") to certain advisors and former employees as payment for services supplied to the Company, at a price of 16.88 pence per share.
Accordingly, application has been made for these New Ordinary Shares to be admitted to trading on AIM. The shares rank pari passu with the existing issued shares of the Company and dealings are expected to commence on 1 July 2013. Following the issue of these new shares the Company has a total of 164,738,247 ordinary shares of 1p each in issue.
For further information, please contact:-
Deltex Medical Group plc |
01243 774 837 investorinfo@deltexmedical.com |
Nigel Keen, Chairman |
|
Ewan Phillips, Chief Executive |
|
Paul Mitchell, Finance Director |
|
|
|
Nominated Adviser & Broker |
|
Arden Partners plc |
020 7614 5900 |
Chris Hardie |
|
Financial Public Relations |
|
Newgate Threadneedle |
020 7653 9850 |
Graham Herring |
|
Caroline Evans-Jones |
|
Heather Armstrong |
|